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Abstract 
Background and Purpose: Caffeine is ubiquitous in foods, supplements, and medications and has been 
hypothesized to be associated with several health-related outcomes, including mental health disorders 
such as anxiety. We explored a possible relationship between caffeine consumption and depression using 
data from the National Health and Nutrition Examination Survey (NHANES). Methods: Data from 1,342 
adult NHANES participants were included. Statistical software for complex survey sample designs was 
used to perform two multivariable logistic regressions with a binary indicator of depression as the 
dependent variable: one using dietary caffeine consumption and one using the caffeine metabolite AAMU 
as the independent variable. Both analyses were adjusted for gender, race/ethnicity, smoking status, and 
use of anti-depressants. Results: We observed a descriptive, albeit non-significant (p = 0.12), pattern of 
increasing odds of depression with increasing levels of the AAMU caffeine metabolite. Conclusion: Our 
finding of a possible association between caffeine metabolite level and depression is compelling because 
it is independent of self-reported caffeine consumption. Prospective studies are warranted to further 
explore the temporal relationship.   
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Introduction 
 
Approximately 85% of the United States 
population consumes at least one caffeinated 
beverage per day, with the vast majority being 
coffee, tea, carbonated soft drinks, and energy 
drinks (Mitchell, Knight, Hockenberry, 
Teplansky, & Hartman, 2014)." Often 
caffeinated products are used to compensate for 
lack of energy and to supplement both physical 
and mental stamina (Richards & Smith, 2016). 
Caffeine is a ubiquitous, unregulated substance 
found not only in beverages, but also in food, 
medications, and supplements (FDA, 2013). Due 
to the increasing presence of caffeine in many of 
these products, the potential long-term effects of 
excess caffeine consumption are a growing 
concern (FDA, 2013).  
 
Caffeine is a psychoactive substance which 
affects the central nervous system and can create 
dependency, tolerance, and withdrawal 
symptoms, similar to the use of regulated and  
 
 
illicit substances (Bergin & Kendler, 2012). The 
reinforcing effects of caffeine have been 
acknowledged and are hypothesized to have 
potential associations with several health 
outcomes including mental health disorders 
(Cappelletti, Daria, Sani, & Aromatario, 2015). 
Although much of the prior research in this area 
has focused on anxiety due to caffeine's 
anxiogenic effects (Bergin & Kendler, 2012), a 
few studies have examined the association 
between caffeine and depression.  A cross-
sectional study of secondary school children 
conducted in the South West of England 
reported a significant positive association 
between caffeine consumption, particularly at 
very high levels (> 1000 mg/week), and both 
depression and anxiety but not stress (Richards 
& Smith, 2015).  The authors pointed out that 
the positive association with depression in their 
population of secondary school children was the 
opposite of findings in an earlier report on an 
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adult population which observed a negative 
association (Smith, 2009). In a cross-sectional 
study of adults in Eastern Canada, analyses 
stratified by sex showed positive associations 
between coffee consumption and depression that 
were significant for women and only for regular 
versus decaffeinated coffee (Yu, Parker, & 
Dummer, 2017). The authors noted that this 
conflicted with a previously published analysis 
of data from the Nurses’ Health Study which 
observed an inverse association with coffee-
drinking (Lucas et al., 2011). An intriguing 
population-based, retrospective study of 
monozygotic twins reported only modest 
positive associations between caffeine and 
depression after accounting for within-family 
effect (Kendler, Myers, & Gardner, 2006). The 
authors refer to this as the “correlated liability 
model”; i.e., genetic and/or environmental 
conditions that predispose to both caffeine 
consumption and depression and suggest that the 
association is non-causal. Even less research 
exists on the relationship between caffeine 
metabolites and depression, with only one 
animal model study showing an inverse 
association between paraxanthine, a caffeine 
metabolite, and sleep (Okuro et al., 2010). To 
our knowledge, no studies have been reported on 
the association between the caffeine metabolite 
5-acetylamino-6-amino-3-methyluracil (AAMU) 
and depression.   
 
To explore the potential relationship between 
caffeine and depression and potentially 
contribute to the limited literature in this area, 
we used the National Health and Nutrition 
Examination Survey (NHANES) database to 
analyze depression as a function of both dietary 
caffeine intake and the urinary metabolite 5-
acetylamino-6-amino-3-methyluracil (AAMU).  
 
Methods 
 
Design 
NHANES is an ongoing, nationally 
representative survey conducted by the National 
Center for Health Statistics at the Centers for 
Disease Control and Prevention (CDC) that 
collects data on the health and nutritional status 
of U.S. adults and children. Since 1999, samples 
have been collected annually but are publicly 
released in 2-year cycles. NHANES 
oversamples certain subgroups, e.g., based on 
age, race, and income, to increase precision of 
statistical estimates. A probability multi-stage 
sampling design is used to maximize efficiency 
of data collection for which there are three 
levels: a household screener, an interview, and 
an examination that takes place in specially-
equipped mobile examination centers. 
Additional details on survey design and 
methodology are available at 
http://www.cdc.gov/nchs/nhanes.htm. The 
interview component of NHANES ascertains 
information on demographic, socioeconomic, 
and health-related factors and includes a 24-hour 
dietary recall assessment and specimen 
collection for laboratory evaluations. The CDC 
Institutional Review Board approved NHANES 
and all participants provided written informed 
consent. 
 
Sample 
The 2009-2010 NHANES cycle included 6,059 
adult (≥ 20 years of age) participants of whom 
1,865 (31%) contributed both dietary caffeine 
and metabolite data; of these, 1,342 (72%) had 
reliable dietary data (per the NHANES 
definition, this required that all relevant 
variables associated with the 24-hour dietary 
recall contain a value) and all potential 
confounders non-missing, thereby constituting 
our analysis population. 
 
Measures 
Depression Screener. In the depression 
screener portion of the NHANES interview, the 
9-item Patient Health Questionnaire (PHQ-9) 
was used to ascertain the frequency of 
depression symptoms during the previous 2 
weeks. Possible responses to each question were 
"not at all," "several days," "more than half the 
days" and "nearly every day" with respective 
scores of 0, 1, 2, and 3. A total score, ranging 
from 0 to 27, was derived by summing over the 
9 items. A score of 10 or higher was used to 
indicate depression, a method that has been 
validated and is commonly used in research 
settings (Manea, Gilbody, & McMillan, 2012). 
For a sensitivity analysis, self-reported use of 
anti-depressants in the month prior to interview 
was added to the definition of depression. 
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Caffeine Intake. Daily dietary caffeine intake, 
an NHANES-derived variable, was obtained 
from the Total Nutrient Intakes data set. Dietary 
intakes were reported via a 24-hour dietary 
recall in which participants reported individual 
foods and drinks consumed during the midnight-
to-midnight 24-hour period prior to the in-
person dietary interview. Coding of interview 
data and conversion to total nutrient intakes 
were conducted by NHANES using the USDA 
Food and Nutrient Database for Dietary Studies, 
5.0 (FNDDS 5.0) 
(http://www.ars.usda.gov/ba/bhnrc/fsrg). The 
FNDDS 5.0 nutrient values were based on the 
USDA National Nutrient Database for Standard 
Reference, release 24 
(http://www.ars.usda.gov/nutrientdata). 
 
Laboratory Analysis. Urine specimens were 
analyzed at the Division of Environmental 
Health Laboratory Sciences, National Center for 
Environmental Health, Centers for Disease 
Control and Prevention; methods have been 
documented and described previously 
(https://wwwn.cdc.gov/Nchs/Nhanes/2009-
2010/CAFE_F.htm). Briefly, caffeine and 14 of 
its metabolites, including AAMU, were 
quantified using high performance liquid 
chromatography-electrospray ionization-tandem 
quadrupole mass spectrometry (HPLC-ESI-
MS/MS) with stable isotope labeled internal 
standards. (National Center for Biotechnology 
Information, 2017). 
 
Statistical Analyses. Analyses were done using 
SAS procedures SURVEYFREQ, 
SURVEYREG and SURVEYLOGISTIC (SAS 
v9.4, SAS Institute, Cary, NC, USA) to account 
for the stratified, multistage probability cluster 
sampling design of NHANES. The NHANES 
stratification variable (SDMVSTRA) and 
Primary Sampling Unit (SDMVPSU) were used 
as the strata and sampling unit variables, 
respectively. NHANES provides sampling 
weights to be used in analyses that account for 
oversampling of certain subgroups, differences 
between the sample and the population due to 
nonresponse, and population sizes. Sampling 
weights for the subsample that provide urine 
specimens (WTSC2YR) were used for all 
analyses since participants had to have non-
missing AAMU to be included in any analysis. 
All statistical tests were two-sided with .05 
significance levels. 
 
Dietary caffeine intake (mg/day) for each 
participant was expressed as the participant’s 
residual value from the linear regression of 
caffeine intake on total energy intake (kcal/day), 
i.e., the difference between the participant’s 
actual dietary caffeine intake and that predicted 
by his or her total energy intake. This approach 
isolates the effect of dietary caffeine intake from 
factors closely associated with total energy 
intake that may be related to depression (e.g., 
body size, metabolic efficiency) without directly 
modeling total energy intake, which is correlated 
with total caffeine intake (Willett, Howe, & 
Kushi, 1997). A categorical variable for dietary 
caffeine intake was derived based on quartiles of 
the distribution of residuals. A categorical 
variable was also derived for AAMU based on 
quartiles of measured levels.  
 
Multivariable logistic regression was used to 
assess the association between the independent 
variables (IVs) dietary caffeine and AAMU and 
the dependent dichotomous variable depression. 
Potential confounders were chosen based on 
literature review of known factors associated 
with depression: age, gender, race/ethnicity, 
education level, income-to-poverty ratio, body 
mass index (BMI), self-reported use of anti-
depressants in the month prior to interview, 
physical activity (measured as metabolic hours, 
a weighted sum of moderate and vigorous 
hours/week of physical activity), smoking status 
(never, former, current), and alcohol 
consumption (measured as drinks/day in the 12 
months prior to interview). From the list of 
potential confounders, covariates to be included 
in the ultimate model were selected using a 
manual process that considered collinearity, 
statistical and clinical significance, influence, 
model fit (as measured by the score statistic), 
predictive ability (as measured by the c statistic), 
and model parsimony. Differences in potential 
confounders between groups defined by self-
reported depression (“No” vs. “Yes”) were 
analyzed by the SAS procedures SURVEYREG 
and SURVEYLOGISTIC for continuous and 
categorical variables, respectively. 
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In order to provide an intuitive interpretation of 
the risk function, odds ratios (ORs) and 95% 
confidence intervals (CIs) were calculated for 
each category of exposure with the lowest 
exposure category as the reference group. P-
values for trend were based on categories of 
exposure modeled as continuous variables. 
There were no a priori hypotheses to be tested 
as this was an exploratory analysis. The same set 
of covariates, selected as described above, were 
used for analyses of both dietary caffeine and 
AAMU. In the covariate selection process as 
well as in the final models, variables were 
modeled as either continuous (age, education 
level, income-to-poverty ratio, BMI, metabolic 
hours, smoking status, alcohol consumption) or 
categorical (gender, race/ethnicity, use of anti-
depressants). 
 
A sensitivity analysis was done using an 
alternative definition of depression: a score of 10 
or higher on the PHQ-9 or self-reported use of 
anti-depressants in the month prior to interview. 
Covariates were selected in a separate process 
from the main analysis since use of anti-
depressants was no longer a candidate covariate. 
 
Results 
 
Differences in potential confounders between 
groups defined by self-reported depression 
(“No” vs. “Yes”) are shown in Table 1. Self-
reported depression was significantly more 
prevalent among women, non-whites, lower-
SES participants (based on education and 
income-to-poverty ratio), current smokers, 
participants with higher BMI, and participants 
with lower levels of alcohol consumption. As 
expected, participants reporting depression were 
also significantly more likely to report use of 
anti-depressants.  
 
Results from both crude and adjusted analyses of 
the relationship between depression and dietary 
caffeine and between depression and AAMU are 
shown in Table 2. After adjustment for 
covariates gender, race/ethnicity, smoking 
status, and use of anti-depressants, there was a 
descriptive, albeit non-significant (p=0.12), 
pattern of increasing odds of depression with 
increasing levels of AAMU. Results from the 
sensitivity analysis were very similar to those 
from the main analysis for both dietary caffeine 
and AAMU (data not shown). 
 
 
Discussion 
 
We observed a descriptive pattern of increasing 
odds of self-reported depression with increasing 
levels of the AAMU caffeine metabolite in 
urine. Although this association did not reach 
statistical significance at the 0.05 level, it is 
nonetheless a compelling observation because 
biomarker data reflect consumption without 
having to rely on self-reporting.  Similarly, our 
analysis using dietary consumption instead of 
AAMU showed elevated odds ratios for the 2
nd
, 
3
rd
, and 4
th
 quartiles of exposure, but no clear 
descriptive trend and a p-value for trend > 0.50. 
Possible explanations for the lack of consistency 
between the two analyses are measurement error 
in self-reported dietary data and lack of control 
for unknown confounders in the analysis of 
dietary data.  
 
Limitations 
Our analysis of depression and caffeine 
exposure is limited due to the retrospective, 
cross-sectional nature of NHANES data. This 
type of data cannot be used to draw inferences 
regarding temporal sequence; e.g., one 
explanation for our observation of increased 
caffeine metabolite in those classified as 
depressed is that depressed individuals self-
medicate with substances such as caffeine.  
Further, both depressive symptoms and dietary 
intake were self-reported. Finally, we restricted 
our analysis to participants with reliable dietary 
data and all potential confounders non-missing, 
which may be a biased subpopulation of 
NHANES adult participants. 
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Table 1 
 
Differences in Potential Confounders by Self-reported Depression 
Parameter 
Depression = NO 
(n = 1,210) 
Depression = YES 
(n = 132) 
p-value
1 
Age [mean (SE)] 46.9 (0.56) 47.3 (0.71) 0.67 
Male [% (SE)] 52.0 (1.77) 34.9 (6.30) 0.04 
Race/Ethnicity [% (SE)]     0.003 
     White 74.4 (3.06) 68.9 (4.95)  
     Hispanic 12.1 (2.59) 9.0 (2.39)  
     African American 9.0 (0.86) 19.5 (3.96)  
     Other 4.5 (0.92) 2.6 (1.70)  
Education Level [% (SE)]     0.01 
     < High School 16.0 (1.46) 29.4 (5.07)  
     High School Grad/GED 21.0 (1.89) 24.4 (4.13)  
     Some College 32.1 (1.20) 31.6 (5.58)  
     College Grad 30.9 (1.74) 14.6 (6.3)  
Income-to-Poverty Ratio Tertile [% (SE)]     < 0.0001 
     < 2.18 30.3 (1.23) 55.3 (5.43)  
     2.18 – 4.35 35.2 (2.09) 22.9 (4.44)  
     > 4.35 34.5 (1.44) 21.9 (3.11)  
Body Mass Index (kg/m
2
) [mean (SE)] 28.7 (0.24) 31.4 (0.94) 0.02 
Used Anti-Depressants in Past Month [% (SE)] 9.4 (1.18) 41.0 (4.93) < 0.0001 
Metabolic Hours Tertile [% (SE)]     0.07 
     < 7.8 29.8 (1.89) 47.1 (5.49)  
     7.8 – 45.7 36.7 (1.83) 24.6 (4.18)  
     > 45.7 33.5 (1.88) 28.3 (5.68)  
Smoking Status [% (SE)]     0.004 
     Never 54.0 (1.03) 35.5 (6.03)  
     Former 26.9 (1.05) 25.3 (4.47)  
     Current 19.2 (0.88) 39.2 (5.36)  
Alcoholic Drinks/Day Tertile [% (SE)]     0.002 
     < 0.5 17.8 (1.42) 33.1 (4.05)  
     0.5 – 1.8 29.1 (1.31) 27.5 (4.59)  
     > 1.8 53.0 (1.75) 39.5 (5.36)  
Total Energy Intake Tertile (kcal/day) [% (SE)]     0.14 
     < 1706 32.3 (1.56) 37.8 (4.44)  
     1706 - 2434 33.9 (1.48) 36.1 (5.78)  
     > 2434 33.8 (1.58) 26.1 (6.25)  
1
 Based on SAS procedure SURVEYREG for continuous variables (including tertile) and 
SURVEYLOGISTIC for categorical variables. 
  
Pogoda, J.M., Patricio, G., McEligot, A.J. / Californian Journal of Health Promotion 2018, Volume 16, Issue 1, Pages 16-23. 
 
 21 
 
Table 2 
 
Multivariable Logistic Regression of Associations between 
Depression, Dietary Caffeine and AAMU Caffeine 
 CRUDE ADJUSTED
1 
Parameter OR (95% CI) p OR (95% CI) 
Dietary Caffeine Quartile of Residual    
2
nd
 1.49 (0.61, 3.63) 0.36 1.64 (0.69, 3.90) 
3
rd
 1.45 (0.57, 3.68) 0.41 1.33 (0.59, 3.03) 
4
th
 1.57 (0.66, 3.73) 0.29 1.40 (0.63, 3.11) 
p-trend   0.32   
AAMU Quartile     
2
nd
 0.98 (0.55, 1.73) 0.93 1.01 (0.59, 1.73) 
3
rd
 1.61 (0.78, 3.31) 0.18 1.62 (0.85, 3.10) 
4
th
 1.67 (0.63, 4.43) 0.28 1.68 (0.65, 4.35) 
p-trend   0.13   
1 
Adjusted for gender, race/ethnicity, smoking status, and use of anti-
depressants. 
 
 
Conclusion 
 
Our results are contradictory to a meta-analysis 
of 12 observational studies of coffee/tea/caffeine 
and depression in which an inverse relationship 
was reported (Grosso, Micek, Castellano, Pajak, 
& Galvano, 2015). Although the meta-analysis 
only included consumption data, the analogous 
NHANES data did not suggest a protective 
effect of caffeine on depression.  However, the 
meta-analysis authors acknowledged that data 
from population-based studies on this 
relationship are “sparse and inconsistent,” as we 
also found in our review of the existing 
literature. Clearly, more rigorous research in 
controlled environments is necessary to answer 
two important questions: (1) is the correlation  
 
 
 
 
between caffeine and depression positive or 
negative, and (2) if there is a positive 
correlation, is it direct or indirect? An indirect 
association is quite plausible since caffeine 
consumption can lead to dependence, which is a 
well-known correlate of depression and other 
mental health disorders (Brady & Sinha, 2005). 
A direct, neurobiological association, whether 
positive or negative, is an interesting hypothesis 
worthy of further study. 
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